EMQN Shortlisted for Quality Assurance and Control Award at the Pharma Industry Awards
EMQN is pleased to announce that it has been shortlisted for the Quality Assurance and Control Award at the Pharma Industry Awards for its entry, External Quality Assessment in Genomics. The shortlisting recognises EMQN’s ongoing commitment to supporting quality, accuracy and confidence in genetic and genomic testing through its international External Quality Assessment (EQA) programmes. […]
EMQN Named Among Top 50 Inspiring Workplaces in the UK & Ireland 2026
EMQN is pleased to announce that we have been recognised among the Top 50 Inspiring Workplaces in the UK & Ireland 2026, as part of the Inspiring Workplaces Awards. This recognition reflects the strength of our people and the culture they create every day, one built on trust, purpose and collaboration. It is through the […]
CADDA Knowledge Transfer Vouchers Funding Awarded
EMQN is pleased to announce that it has been awarded funding through the CADDA Knowledge Transfer Vouchers scheme for the project “Engineered CYP2C19 Cell Lines for Point‑of‑Care Test (POCT) Quality Assessment”, delivered in collaboration with The University of Manchester.This project will apply CRISPR‑Cas9 genome editing to develop high‑quality, well‑characterised reference materials containing clinically important variants […]
EMQN Named Finalist in the 2026 UK & Ireland Inspiring Workplaces Awards
EMQN CIC is proud to announce that it has been named a finalist in the 2026 UK & Ireland Inspiring Workplaces Awards, in association with Prezzee, placing the organisation among a prestigious group of employers recognised for putting people at the heart of their culture. The Inspiring Workplaces Awards are recognised globally as the world’s […]
EMQN and Ridacom Join Forces to Elevate Genomics Quality in Southeast Europe
We’re thrilled to announce a strategic partnership between EMQN CIC and Ridacom Ltd, a leading provider of laboratory solutions across Bulgaria, Greece, and Albania. This exciting collaboration marks a major milestone in our mission to make high-quality genomics accessible across Southeast Europe. Through this partnership, Ridacom will become EMQN’s trusted regional distributor, helping clinical laboratories […]
Microbix Assisting EMQN with Second Genetic-Test EQA Program
Helping Ensure Appropriate Dosing of Widely-Used Anti-Clotting Drugs MISSISSAUGA, CANADA & MANCHESTER, UK – September 23, 2025 – Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, and EMQN CIC (EMQN), a global supplier of laboratory external quality assessment (“EQA”) schemes for human genomic testing, announce the go-live of […]